Patent ID: 9726659
Date: 2017-08-08
CPC Classifications: A61K,A61P,C07D,G01N,Y10T

Claim:
1. A method of treating impaired glucose homeostasis comprising: (a) detecting a test level of 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) in a sample from a subject; and (b) comparing the test level of CMPF to a control level wherein: (c) administering to the subject identified as having, or at risk of developing, impaired glucose homeostasis in part b) an agent suitable for the treatment of impaired glucose homeostasis selected from the group consisting of a CMPF inhibitor, insulin, metformin, GLP-1 receptor agonist, GLP-1 analog, sulfonylureas, or insulin sensitizer.